Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06658912

Planning Grant for TOPS for Breast Cancer Survivors

The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors.

This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and provide feedback. Focus groups will be made up of women who are breast cancer survivors.

The second part includes taking the feedback received from these focus groups and use this feedback to tailor TOPS classes for breast cancer survivors.

This ClinicalTrials.gov record is specific to the second part of the study.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year–90 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors.

This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and have the groups provide feedback. Focus groups will be made up of breast cancer survivors that have recruited from local support group chapters. The goal is to recruit approximately 25 people to take part in these focus groups. Meetings of focus groups will be conducted remotely through Zoom and will be recorded. A meeting of the focus group will last anywhere from 60-90 minutes.

The information gathered from these groups will be used to improve the materials which lead to part two of the study.

The second part includes using these materials in TOPS classes that are tailored for breast cancer survivors and determining if the TOPS classes are effective on those who attend the classes. Effectiveness of the class will be determined by the weight loss of the participant and an impact on their heart health.

For the first 6 months, participants will attend dietician-led TOPS sessions conducted virtually through Zoom. Participants' weight will be measured as instructed using a Bluetooth scale that will send their weight measurements back to the team. Participants will also measure their blood pressure through a Bluetooth device provided by the study team.

After 6 months, participants will be asked to join a TOPS chapter in their community. The study team will help them local a chapter that is convenient for them. They must attend these classes for another 6 months. Total time in this portion of the study will be approximately 12 months.

While on study, in addition to measuring their weight and blood pressure via the Bluetooth devices, the study team asks that participants also have their blood collected. Participants will have to go to their local LabCorp facility to have blood drawn at baseline visit, 3 months, 6 months, and 12 months. Participants will also be asked to complete surveys via their email. Surveys will ask about participant's current medications and ask them to score their overall health at that time.

This ClinicalTrials.gov record is specific to the second part of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Aim 2 Inclusion Criteria:

  • women diagnosed with breast cancer with BMI ≥ 25 kg/m2 after completion of primary therapy (surgery, radiation, adjuvant or neo-adjuvant chemotherapy).

Aim 2 Exclusion Criteria:

  • Those whose oncology providers do not agree with their participation in a weight loss program
  • History of Type II Diabetes Mellitus
  • those participating in another weight loss program
  • those taking a weight loss medication
  • those without smart phones or internet connections or the ability to attend meetings via Zoom

Treatment and study plan

TOPS Classes

Other

Attend Dietician-Led Sessions

Primary outcomes

  1. Number of invitations sent through the electronic health record to get 25 individuals consented to the study

    Time frame: 1-2 months

  2. Percentage of TOPS group session attendance

    Time frame: 12 months

    This will be calculated as number of sessions attended divided by total number of sessions offered

  3. Number of participants who stay in the study

    Time frame: 3 months, 6 months, 9 months, 12 months

  4. Number of participants who transition from the initiation phase to the maintenance phase

    Time frame: 12 months

  5. Number of participants who continue to transmit weight and BP data once they transition to the maintenance phase

    Time frame: 9 months, 12 months

  6. Percent of Weight Loss

    Time frame: Up to 12 Months

Secondary outcomes

  1. Cardiovascular Disease (CVD) risk factors as measured by blood pressure

    Time frame: up to 12 months

  2. Cardiovascular Disease (CVD) risk factors as measured by hemoglobin A1c

    Time frame: up to 12 months

  3. Cardiovascular Disease (CVD) risk factors as measured by glucose

    Time frame: up to 12 months

  4. Percentage of participants who get blood drawn

    Time frame: Baseline, 3 months, 6 months,12 months

  5. Quality of Life (QOL) as measured by survey

    Time frame: up to 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Nia S Mitchell, MD

CONTACT

[email protected]

833-637-8839

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Planning Grant for Take Off Pounds Sensibly (TOPS) Classes for Breast Cancer Survivors

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Oct 26, 2024
Registry last updated
Apr 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.